(R)-(+)-SKF38393 hydrochloride, D1 partial agonist

Be the first to review this product! Submit a review

|

(1 Publication)

MW 291.77 Da, Purity >98%. Selective D1 receptor partial agonist. Active enantiomer of (±)-SKF-38393 (ab120740).

View Alternative Names

15-PGDH, 15-hydroxyprostaglandin dehydrogenase [NAD+], 3',5'-cyclic AMP synthetase, 70 kDa lysosomal alpha-glucosidase, A3G, ABC3G_HUMAN, AC-III, AC2, AC6, ACVI, ADCY3_HUMAN, ADCY6_HUMAN, ADCYB, APOBEC-related cytidine deaminase, APOBEC-related protein, APOBEC-related protein 9, APOBEC3G, ARCD, ARP-9, ATP pyrophosphate lyase 2, ATP pyrophosphate-lyase, ATP pyrophosphate-lyase 3, ATP pyrophosphate-lyase 6, ATP pyrophosphate-lyase 8, Acid Maltase, Acid alpha glucosidase, Adenylate cyclase, Adenylate cyclase 2, Adenylate cyclase 2 (brain), Adenylate cyclase 6, Adenylate cyclase 8, Adenylate cyclase II, Adenylate cyclase type 2, Adenylate cyclase type 3, Adenylate cyclase type 6, Adenylate cyclase type II, Adenylate cyclase type III, Adenylate cyclase type VI, Adenylate cyclase type VIII, Adenylyl cyclase 3, Adenylyl cyclase 6, Adenylyl cyclase 8 brain, Aglucosidase Alfa, Alpha-glucosidase, Apolipoprotein B editing enzyme catalytic polypeptide like 3G, Apolipoprotein B mRNA editing enzyme catalytic polypeptide 3G, Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3G, Apolipoprotein B mRNA editing enzyme catalytic subunit 3G, Brain adenylate cyclase 8, CEM-15, Ca(2+)-inhibitable adenylyl cyclase, Ca(2+)/calmodulin-activated adenylyl cyclase, D(1A) dopamine receptor, D(1B) dopamine receptor, D(2) dopamine receptor, D(3) dopamine receptor, D(5) dopamine receptor, D1 beta dopamine receptor, D1A dopamine receptor, D1B dopamine receptor, D2 dopamine receptor, D2DR, D2R, D5 dopamine receptor, DADR, DBDR, DKFZp779F075, DNA dC dU editing enzyme APOBEC 3G, DNA dC->dU editing enzyme, DNA dC->dU-editing enzyme APOBEC-3G, DNA replication inhibitor, DRD 1A, DRD 1B, DRD1L2, DRD1_HUMAN, DRD2_HUMAN, DRD5_HUMAN, Dopamine D1 receptor, Dopamine D2 receptor, Dopamine D3 receptor, Dopamine D5 receptor, Dopamine receptor D1B, Dopamine receptor D2, EC 3.5.4.-, EC 4.6.1.1, FLJ12740, FLJ16822, FLJ45092, GEMI_HUMAN, GMNN, Geminin, Geminin DNA replication inhibitor, Glucosidase alpha, Glucosidase alpha acid, Glucosidase alpha acid (Pompe disease glycogen storage disease type II), HBAC1, HBAC2, Hpgd, Hydroxyprostaglandin dehydrogenase 15 (NAD), KIAA0422, KIAA1060, LYAG_HUMAN, Lysosomal Alpha-Glucosidase, MDS019, MGC10601, MGC133314, NAD+ dependent 15 hydroxyprostaglandin dehydrogenase, OTTHUMP00000028911, OTTHUMP00000039393, OTTHUMP00000218960, OTTHUMP00000219016, OTTHUMP00000219018, PGDH1, PGDH_HUMAN, PHOAR1, Particulate Guanylate Cyclase E, Prostaglandin dehydrogenase 1, RP3 369A17.3, SDR36C1, Short chain dehydrogenase/reductase family 36C member 1, Type II adenylate cyclase, adenylate cyclase 3, apolipoprotein B mRNA editing enzyme cytidine deaminase, apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like, bK150C2.7, dJ494G10.1, deoxycytidine deaminase, dopamine receptor D1, dopamine receptor D5, olfactive type, phorbolin-like protein, phorbolin-like protein MDS019